By Gabriel Paijo 
A landmark study conducted by a multidisciplinary team of scientists in Brazil has uncovered a critical biological mechanism that allows pancreatic cancer to spread aggressively during its earliest stages. Published in the prestigious journal Molecular and Cellular Endocrinology, the research identifies a specific protein, periostin, as a primary driver behind the ability of pancreatic cancer cells to infiltrate nearby nerves. This process, known as perineural invasion, is a hallmark of the disease’s lethality and serves as a precursor to widespread metastasis. By mapping the complex interactions between tumor cells and the surrounding healthy tissue, the study offers a new roadmap for the development of precision therapies designed to halt the progression of one of the world’s most recalcitrant cancers.
The research was primarily conducted at the Center for Research on Inflammatory Diseases (CRID), a Research, Innovation, and Dissemination Center (RIDC) funded by the São Paulo Research Foundation (FAPESP). The team, led by researcher Carlos Alberto de Carvalho Fraga and principal investigator Helder Nakaya, utilized cutting-edge spatial transcriptomics to observe how pancreatic tumors "reprogram" their environment. Rather than existing as isolated masses of malignant cells, these tumors actively recruit and modify surrounding healthy cells to facilitate their expansion.
Understanding the Aggressive Nature of Pancreatic Adenocarcinoma
Pancreatic cancer remains one of the most formidable challenges in modern oncology. The most prevalent form of the disease is pancreatic ductal adenocarcinoma (PDAC), which originates in the glandular cells responsible for secreting digestive enzymes. PDAC accounts for approximately 90% of all pancreatic cancer diagnoses and is characterized by its rapid progression and high resistance to conventional therapies.
Statistically, the outlook for patients diagnosed with pancreatic cancer is sobering. According to global health data, there are approximately 510,000 new cases of pancreatic cancer diagnosed annually, with the mortality rate nearly mirroring the incidence rate. In Brazil, the National Cancer Institute (INCA) estimates roughly 11,000 new cases and 13,000 deaths each year—a discrepancy that highlights the late-stage detection and rapid decline often associated with the disease.
"Pancreatic cancer is notoriously aggressive and difficult to treat," explains Pedro Luiz Serrano Uson Junior, an oncologist and co-author of the study. "Currently, only about 10% of patients achieve long-term survival, defined as five years post-diagnosis. The reason for this low survival rate is often tied to how quickly the cancer escapes the primary site."
The Role of the Tumor Microenvironment and Stellate Cells
A central finding of the Brazilian study is that the tumor does not act in a vacuum. Instead, it relies on a "support system" within the pancreatic stroma—the connective tissue that surrounds the organ’s functional cells. The researchers focused on pancreatic stellate cells (PSCs), which are typically dormant in a healthy pancreas but become "activated" in the presence of a tumor.
Once activated, these stellate cells begin producing excessive amounts of periostin, a protein involved in tissue remodeling. Periostin plays a dual role: it helps restructure the extracellular matrix (the physical scaffold of the tissue) and acts as a biochemical signal that encourages cancer cells to move. This interaction effectively transforms the surrounding healthy tissue into a staging ground for invasion.
The study utilized 24 pancreatic cancer samples, applying advanced computational tools to analyze the activity of thousands of genes at the single-cell level. By integrating these data points, the researchers were able to see exactly where periostin was being produced and how it correlated with the proximity of nerve fibers.
Deciphering the Mechanism of Perineural Invasion
Perineural invasion (PNI) is perhaps the most dangerous trait of pancreatic adenocarcinoma. It occurs when cancer cells wrap around or penetrate the nerve bundles that permeate the pancreas. Because the nervous system is an interconnected network that extends throughout the body, these nerves serve as "highways" for the cancer, allowing it to bypass traditional barriers and reach distant organs.
"Perineural invasion is a significant marker of cancer aggressiveness," says Uson. "It is not just a secondary effect; it is a primary method of escape. When cancer cells hit a nerve, they have a direct route to spread."
The research indicates that the remodeling of the extracellular matrix by periostin is what "paves the road" for this invasion. By breaking down the structural integrity of the healthy tissue and replacing it with a more permissive environment, the stellate cells and periostin allow the tumor to reach the nerve bundles much earlier than previously thought. This explains why many patients already have metastatic disease at the time of their initial diagnosis, even when the primary tumor appears relatively small.
Methodological Breakthroughs: Spatial Transcriptomics and Public Data
The success of the study relied heavily on the use of spatial transcriptomics, a technology that allows scientists to see which genes are turned on in specific cells while maintaining the context of their location within the tissue. This is a significant advancement over "bulk" sequencing, which grinds up tissue samples and provides an average of gene activity, losing the vital "map" of the tumor’s architecture.
"We were able to integrate data from dozens of samples with extremely powerful resolution," says Helder Nakaya, who also serves as a senior researcher at Einstein Israelite Hospital and a professor at the University of São Paulo. "This allowed us to ask and answer new questions that the original authors of the public datasets we utilized hadn’t considered."
By leveraging large public databases and applying their own analytical frameworks, the CRID team was able to validate their findings across diverse patient populations. This robust approach confirms that the periostin-stellate cell axis is a consistent feature of aggressive pancreatic cancer across different genomic backgrounds.
The Desmoplastic Reaction: Why Current Treatments Often Fail
One of the greatest hurdles in treating pancreatic cancer is the "desmoplastic reaction"—the formation of dense, fibrous tissue around the tumor. This reaction is essentially the body’s attempt to wall off the cancer, but it inadvertently creates a protective fortress for the tumor.
The study notes that the same stellate cells and periostin involved in nerve invasion also contribute to this fibrous buildup. This hardened tissue increases the internal pressure of the tumor and collapses local blood vessels. Consequently, chemotherapy drugs and immunotherapy agents, which travel through the bloodstream, cannot penetrate the tumor mass effectively.
"The microenvironment becomes a physical barrier," Uson explains. "That is why we see such poor responses to drugs that work well in other types of cancer. The medicine simply cannot reach the target."
The Path Toward Precision Medicine: Targeting Periostin
The identification of periostin as a key facilitator of both nerve invasion and the desmoplastic reaction makes it a high-priority target for future drug development. The researchers suggest that by blocking periostin or inhibiting the activation of stellate cells, it may be possible to "soften" the tumor environment and prevent the cancer from reaching the nervous system.
Clinical trials are already underway for other types of cancer—such as breast and lung cancer—testing monoclonal antibodies designed to block periostin. The Brazilian team believes these efforts could be pivoted toward pancreatic cancer. If successful, such a treatment could be used in combination with standard chemotherapy, breaking down the tumor’s defenses so the drugs can do their work.
"This is the essence of precision medicine," says Uson. "If we can develop antibodies or drugs that block these specific molecular changes, we can prevent the tumor from acquiring its invasive capacity so early in the process."
Global and Regional Implications for Public Health
The findings have significant implications for how pancreatic cancer is managed, particularly in terms of surgical intervention and post-operative care. Currently, perineural invasion is often only discovered during a biopsy after the tumor has been surgically removed. By then, the "escape" has often already occurred.
If researchers can develop biomarkers to detect high levels of periostin or evidence of nerve invasion through blood tests or advanced imaging before surgery, clinicians could tailor treatment plans more effectively. For example, patients with high periostin activity might receive more aggressive systemic therapy before attempting surgery.
Furthermore, the study highlights the importance of international collaboration and the use of open-access scientific data. By using public databases, the Brazilian researchers were able to conduct high-level genomic research that has global relevance, contributing to a shared understanding of cancer biology that transcends national borders.
Conclusion: A New Era in Oncology Research
The work produced by the Center for Research on Inflammatory Diseases marks a significant step forward in the fight against pancreatic cancer. By shifting the focus from the cancer cells themselves to the "reprogrammed" environment that supports them, the researchers have identified a vulnerability in the disease’s most effective weapon.
"Precision medicine is advancing rapidly," Uson concludes. "In the future, we will not just treat a ‘pancreatic tumor’; we will treat a specific set of genomic and molecular changes. This study is a major contribution to that shift, providing a new target that could eventually improve the survival and quality of life for thousands of patients."
As the scientific community moves toward the next phase of this research—translating these molecular insights into clinical applications—the focus will remain on stopping the invasion before it begins. While the road to a cure for pancreatic cancer remains long, the discovery of the role played by periostin and stellate cells provides a crucial new path forward.
